Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are…
- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the…